ScreenerHero

CGENCompugen Ltd.

NAS · US · Healthcare · Biotechnology · cgen.com
2.615USDMkt Cap: 247.70M $P/E: 6.88

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap247.70M $
Enterprise Value125.43M $
Revenue (TTM)74.00M $
Gross Profit63.51M $
Net Income (TTM)35.34M $
Revenue/Share0.7850 USD
Last Price2.615 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)6.88
P/E (Forward)-7.13
PEG1.29
EV/EBITDA4.09
EV/Revenue1.69
P/S3.35
P/B2.79
EPS (TTM)0.38
EPS (Forward)-0.37
52W Range
2.6103% of range2.765
52W High2.765 USD
52W Low2.610 USD
Profitability
Gross Margin87.29%
Oper. Margin-339.62%
EBITDA Margin41.45%
Profit Margin48.57%
ROE34.40%
ROA22.57%
Growth
Revenue Growth107.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF31.63M $
CapEx (TTM)306.00K $
FCF Margin30.02%
FCF Yield8.97%
Net Debt-122.28M $
Net Debt/EBITDA-3.99
Balance Sheet
Debt/Equity0.03
Current Ratio5.72
Quick Ratio5.72
Book Value/Sh0.9370 USD
Cash/Share1.323 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.600 USD
Upside (mean)+75.9%
Target Range4.000 USD – 6.000 USD
$4.000+75.9% to mean$6.000
# Analysts5
Ownership
Shares Out.94.72M
Float92.67M
Insiders2.10%
Institutions15.20%
Short Interest
Short Ratio11.4d
Short % Float2.97%
Short % Out.2.97%
Shares Short2.81M
Short (prev mo.)2.80M
Technical
SMA 502.288 (+14.3%)
SMA 2002.122 (+23.2%)
Beta2.78
S&P 52W Chg19.18%
Avg Vol (30d)446.64K
Avg Vol (10d)339.98K
Technical Indicators
RSI (14)62.4
MACD0.0564
MACD Signal0.0331
MACD Hist.+0.0233
BB Upper2.597 USD
BB Middle2.391 USD
BB Lower2.184 USD
BB Width17.26%
ATR (14)0.1221 USD
Vol Ratio (20d)1.54x